Related Experiment Video
Updated: Jan 25, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated
Dhong Hyo Kho1, Mohammed Hafiz Uddin1, Madhumita Chatterjee1
1Departments of Oncology and Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
Abstract:
GP78 is an autocrine motility factor (AMF) receptor (AMFR) with E3 ubiquitin ligase activity that plays a significant role in tumor cell proliferation, motility, and metastasis. Aberrant extracellular signal-regulated kinase (ERK) activation via receptor tyrosine kinases promotes tumor proliferation and invasion. The activation of GP78 leads to ERK activation, but its underlying mechanism is not fully understood. Here, we show that GP78 is required for epidermal growth factor receptor (EGFR)-mediated ERK activation. On one hand, GP78 interacts with and promotes the ubiquitination and subsequent degradation of dual-specificity phosphatase 1 (DUSP1), an endogenous negative regulator of mitogen-activated protein kinases (MAPKs), resulting in ERK activation. On the other hand, GP78 maintains the activation status of EGFR, as evidenced by the fact that EGF fails to induce EGFR phosphorylation in GP78-deficient cells. By the regulation of both EGFR and ERK activation, GP78 promotes cell proliferation, motility, and invasion. Therefore, this study identifies a previously unknown signaling pathway by which GP78 stimulates ERK activation via DUSP1 degradation to mediate EGFR-dependent cancer cell proliferation and invasion.
Insights
GP78 receptor activates cancer cell proliferation and invasion by promoting ERK pathway signaling. It achieves this by degrading DUSP1 and maintaining EGFR activation, revealing a novel cancer progression mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- GP78 (also known as AMFR) is an E3 ubiquitin ligase implicated in tumor progression.
- Aberrant ERK activation is a hallmark of cancer, driving proliferation and invasion.
- The precise mechanism linking GP78 to ERK activation remains unclear.
Purpose of the Study:
- To elucidate the role of GP78 in epidermal growth factor receptor (EGFR)-mediated ERK activation.
- To identify the molecular players involved in GP78-driven signaling pathways in cancer cells.
Main Methods:
- Investigated GP78's interaction with DUSP1 and EGFR.
- Utilized ubiquitination assays to assess DUSP1 degradation.
- Performed EGFR phosphorylation assays in GP78-deficient cells.
Main Results:
- GP78 interacts with and promotes the ubiquitination and degradation of DUSP1, a negative regulator of MAPKs.
- GP78 is essential for EGFR activation, as EGF fails to induce EGFR phosphorylation in GP78-deficient cells.
- GP78 enhances cancer cell proliferation, motility, and invasion through EGFR and ERK regulation.
Conclusions:
- GP78 activates ERK signaling by degrading DUSP1 and sustaining EGFR activation.
- This study uncovers a novel GP78-mediated signaling axis crucial for EGFR-dependent cancer progression.
- Targeting GP78 may offer a therapeutic strategy for inhibiting cancer cell proliferation and invasion.
More Related Videos
11:00Photostimulation by Femtosecond Laser Activates Extracellular-signal-regulated Kinase ERK Signaling or Mitochondrial Events in Target Cells
Published on: July 6, 2019
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Intracellular Signaling Cascades
Cooperative Binding of Transcription Regulators
Yeast Signaling
Endocrine Signaling